James Hassard - Net Worth and Insider Trading
James Hassard Net Worth
The estimated net worth of James Hassard is at least $4 Million dollars as of 2024-08-24. James Hassard is the Chief Commercial Officer of Arrowhead Pharmaceuticals Inc and owns about 105,750 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $3 Million. James Hassard is also the Chief Commercial Officer of Crinetics Pharmaceuticals Inc and owns about 29,259 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $2 Million. Details can be seen in James Hassard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Hassard has not made any transactions after 2024-07-05 and currently still holds the listed stock(s).
Transaction Summary of James Hassard
James Hassard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Hassard owns 2 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , and Crinetics Pharmaceuticals Inc (CRNX) .
Click here to see the complete history of James Hassard’s form 4 insider trades.
Insider Ownership Summary of James Hassard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2021-06-22 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals Inc | 2024-07-05 | Chief Commercial Officer |
James Hassard Latest Holdings Summary
James Hassard currently owns a total of 2 stocks. Among these stocks, James Hassard owns 105,750 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of June 22, 2021, with a value of $3 Million and a weighting of 62.76%. James Hassard also owns 29,259 shares of Crinetics Pharmaceuticals Inc (CRNX) as of July 5, 2024, with a value of $2 Million and a weighting of 37.24%.
Latest Holdings of James Hassard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2021-06-22 | 105,750 | 24.78 | 2,620,485 |
| CRNX | Crinetics Pharmaceuticals Inc | 2024-07-05 | 29,259 | 53.15 | 1,555,116 |
Holding Weightings of James Hassard
James Hassard Form 4 Trading Tracker
According to the SEC Form 4 filings, James Hassard has made a total of 2 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 3,625 shares on June 22, 2021, which brought James Hassard around $323,422.
According to the SEC Form 4 filings, James Hassard has made a total of 2 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 15,000 shares on July 5, 2024, which brought James Hassard around $661,200.
Insider Trading History of James Hassard
- 1
James Hassard Trading Performance
James Hassard Ownership Network
James Hassard Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
James Hassard is the Chief Commercial Officer of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, James Hassard made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 266,472 shares made by Christopher Richard Anzalone , a net sale of 55,383 shares made by James C Hamilton , and a net sale of 71,104 shares made by Kenneth Allen Myszkowski .
In summary, during the past 3 months, insiders sold 9,394 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 9,394 shares. During the past 18 months, 509,331 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 506,331 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
James Hassard Mailing Address
Above is the net worth, insider trading, and ownership report for James Hassard. You might contact James Hassard via mailing address: 177 E Colorado Blvd, Ste 700, Pasadena Ca 91105.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
